What is adequate management to preserve erectile function after unilateral nerve-sparing radical prostatectomy?
Hatzimouratidis
Konstantinos
K
Second Department of Urology and Center for Sexual and Reproductive Health, Aristotle University of Thessaloniki, Greece. kchatzim@med.auth.gr
Moysidis
Kyriakos
K
Bekos
Athanasios
A
Giakoumelos
Alexandros
A
Hatzichristou
Dimitrios
D
D007172:Erectile Dysfunction / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011467:Prostate / Q000294:innervation* / Q000601:surgery*; D011468:Prostatectomy / Q000009:adverse effects*
D010726:Phosphodiesterase Inhibitors